How antimalarial drug resistance affects post-treatment prophylaxis
Open Access
- 11 January 2008
- journal article
- review article
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 9
Abstract
Slowly eliminated antimalarial drugs suppress malaria reinfections for a period of time determined by the dose, the pharmacokinetic properties of the drug, and the susceptibility of the infecting parasites. This effect is called post-treatment prophylaxis (PTP). The clinical benefits of preventing recrudescence (reflecting treatment efficacy) compared with preventing reinfection (reflecting PTP) need further assessment. Antimalarial drug resistance shortens PTP. While blood concentrations are in the terminal elimination phase, the degree of shortening may be estimated from measurements of in-vitro susceptibility and the terminal elimination half-life. More information is needed on PTP following intermittent preventive treatments, and on the relationship between the duration of PTP and immunity, so that policy recommendations can have a firmer evidence base.Keywords
This publication has 18 references indexed in Scilit:
- Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyJAMA, 2007
- Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?Malaria Journal, 2007
- MATHEMATICAL MODEL OF THE FIRST WAVE OF PLASMODIUM FALCIPARUM ASEXUAL PARASITEMIA IN NON-IMMUNE AND VACCINATED INDIVIDUALSThe American Journal of Tropical Medicine and Hygiene, 2006
- Intermittent Presumptive Treatment for MalariaPLOS Medicine, 2005
- The origins of antimalarial drug resistanceTrends in Parasitology, 2004
- The assessment of antimalarial drug efficacyTrends in Parasitology, 2002
- The evolution of drug–resistant malaria: the role of drug elimination half–lifePhilosophical Transactions of the Royal Society B: Biological Sciences, 2002
- Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infectionParasitology, 2002
- The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analysesParasitology Today, 1997
- Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-lifeTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993